Neonatal Package Study in Rural District of Pakistan

NCT ID: NCT02279381

Last Updated: 2016-06-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

1450 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Neonatal mortality has been a notable health issue in Pakistan. Considering the importance of the issue and well recognized interventions the investigators are proposing a randomized controlled trial in a rural district of Pakistan which will evaluate the effectiveness of a neonatal package comprised of the standard neonatal care, Kangaroo Mother Care (KMC) and application of chlorhexidine compared with standard neonatal care coupled with application of chlorhexidine and essential neonatal care alone. The investigators anticipate that this study will provide an evidence base way forward benefiting the children of Pakistan.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The global neonatal mortality burden is one of the imminent factors which derail the achievement of the MDG 4 in many developing countries including Pakistan. Four million infants infants die in their first 28 days of their lives which account for about 40% of the total under-five mortality. The burden of neonatal mortality in Pakistan is alarming as the current neonatal mortality rate (NMR) is 55 per 1000 live births, third worst in the world. The major causes of these deaths are infections, preterm births and birth asphyxia which are avoidable. Despite many initiatives the NMR remains unchanged since last decade in Pakistan.

Literature shows that low cost facility and community based interventions can reduce NMR significantly. Early neonatal care, application of chlorhexidine for cord care and Kangaroo Mother Care (KMC) have been recognized as effective intervention in reduction of neonatal morbidity and subsequently neonatal mortality in many developing countries. However these interventions have never been tested as a package and data about their combined effect is scarce both in Pakistan and developing countries.

Considering the importance of the issue and well recognized interventions we are proposing a randomized controlled trial in a rural district of Pakistan which will evaluate the effectiveness of a neonatal package comprised of the standard neonatal care, KMC and application of chlorhexidine compared with standard neonatal care coupled with application of chlorhexidine and standard neonatal care alone. We anticipate that this study will provide an evidence base way forward benefiting the children of Pakistan.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neonatal Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group B

1. Essential Neonatal Care
2. Application of 4% Chlorhexidine
3. Education and counseling for mothers and care providers

Group Type EXPERIMENTAL

Chlorhexidine

Intervention Type DRUG

4% chlorhexidine will be applied to the umbilical stump from day 1 to day 10

Essential Neonatal Care

Intervention Type OTHER

Essential Neonatal Care ensures delayed bathing, use of colostrum, exclusive breast feeding, skin to skin care for hypothermia, dry cord care, eye care and immunization for the newborn

Control group

1. Essential Neonatal Care
2. Education and counseling for mothers and care providers

Group Type ACTIVE_COMPARATOR

Essential Neonatal Care

Intervention Type OTHER

Essential Neonatal Care ensures delayed bathing, use of colostrum, exclusive breast feeding, skin to skin care for hypothermia, dry cord care, eye care and immunization for the newborn

Intervention group A

1. Essential Neonatal Care
2. Kangaroo mother Care
3. Application of 4% Chlorhexidine
4. Education and counseling for mothers and care providers

Group Type EXPERIMENTAL

Chlorhexidine

Intervention Type DRUG

4% chlorhexidine will be applied to the umbilical stump from day 1 to day 10

Kangaroo Mother Care

Intervention Type OTHER

Skin to Skin Care which is Kangaroo mother care will be carried out by mother from Day 1 till the study completion

Essential Neonatal Care

Intervention Type OTHER

Essential Neonatal Care ensures delayed bathing, use of colostrum, exclusive breast feeding, skin to skin care for hypothermia, dry cord care, eye care and immunization for the newborn

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chlorhexidine

4% chlorhexidine will be applied to the umbilical stump from day 1 to day 10

Intervention Type DRUG

Kangaroo Mother Care

Skin to Skin Care which is Kangaroo mother care will be carried out by mother from Day 1 till the study completion

Intervention Type OTHER

Essential Neonatal Care

Essential Neonatal Care ensures delayed bathing, use of colostrum, exclusive breast feeding, skin to skin care for hypothermia, dry cord care, eye care and immunization for the newborn

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Antiseptic

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All healthy newborns born in the study settings will be systematically enrolled in the trial after prior consent.

Exclusion Criteria

* Infants with congenital/birth defects,
* any localized infection on the peri umbilical region at the time of birth or application of
* any other material such as dung etc before enrollment on the cord.
Minimum Eligible Age

1 Day

Maximum Eligible Age

28 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sydney

OTHER

Sponsor Role collaborator

The International Federation of Red Cross and Red Crescent Societies

OTHER

Sponsor Role collaborator

Aga Khan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Sajid Bashir Soofi

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muhammad Atif Habib, MPH

Role: STUDY_DIRECTOR

Aga Khan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taluka Hospital KN Shah

Dadu, Sindh, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3106-Ped-ERC-14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Zambia Chlorhexidine Application Trial
NCT01241318 COMPLETED PHASE2/PHASE3